News | August 11, 2022
Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Subscribe To Our Newsletter & Stay Updated
